Mkt, Biotech Down Slightly Friday 10.02

Friday 10.02.09:
DOW -21(.2%) @9,488..NAS -9(.46%) @2,048..SP500 -4.6(.45%) @1,025

BIO-Stem Index: -1.21(-.87%) @138.15 (+38.15% ytd)
BIO-ETF Index: -.59(-.54%) @110.33 (+10.34% ytd)

The market dropped a fraction on Friday, losing just a half percent overall. Biotech fell about as much, stem cells a little more, .87%, with only 8 up, 23 down. Trimeris (TMRS) rose 37% on a takeover. ONCY as up 20% after an FDA agreement to conduct Phase 3 trials on head and neck cancers with their platinum based therapy, which show 42% response rate and 75% clinical benefit rate in Phase 2 data from the U.K, to be released in detail in late 2009.

Stem Cell Stocks (8 up, 23 down)
Big Winners: ABT 2.4%, ALXN 2.2%, OSIR 3.65%
Losers: AVII -4.3%, CUR -2.7%, OPXA -7.3%, SQNM -5.2% (the fall continues...)

Swine Flu Stocks
AVII -4.3%, BCRX +7.3%, DVAX -3.6%, GILD -1.7%, INHX -.9%, INO +11.2%, NVAX -6.3%, SIGA +.9%, SVA -4.6%
Other Flu: APT -3.3%, CRXL -1%, CVM -7.3%, HEB +2%, PURE -3.2%, VICL -2.7%

Other Biotech
Big Winners: ACAD +4.4%, AEZA +4.2%, CLDX +4.2%, KERX +8.2%, ONCY +20.4%, SLXP +3.5%
Losers: ADLR -3.2%, ANIK -3.7%, BDSM -3.5%, CGEN -5.3%, CPD -3%, CTIC -5.8%, DSCO -11.6%, GTXI -7.6%, IMMU -4.1%, INSM -3.1%, LTRX -4.1%, MATK -3.7%, MED -3%, NBIX -3.4%, NVGN -10.9%, QGLY -3.5%, VVUS -3.9%

SubMicro: CPRX -18%, GETA -14%, ORXE +7%, PMD -7.5%, TGX -4.3%, THLD +4.4%, TRMS +37%

New Intraday Highs: SLXP

Disclosure: Long BCRX, BSDM, CVM, DNDN